Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vivoryon Therapeutics NV
VVYCurrent price
2.06 EUR
-0.04 EUR (-1.90%)
Last closed
2.1 EUR
Company
www.vivoryon.com
ISIN
DE0007921835
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Amsterdam
Capitalization
58 144 710 EUR
Yield for 12 month
-74.41 %
1Y
3Y
5Y
10Y
15Y
VVY
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany. Address: Weinbergweg 22, Halle, Germany, 06120
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.75 EURP/E ratio
–Dividend Yield
–Current Year
-3 662 035 EUR
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 130 939 EUR
Last Year
-162 869 EUR
Current Quarter
-79 917 EUR
Last Quarter
–
Key Figures VVY
1 year
3 years
5 years
10 years
EBITDA
-31 628 044 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-62.86 %
PEG Ratio
–
Return On Equity TTM
-112.35 %
Wall Street Target Price
17.75 EUR
Revenue TTM
-3 662 035 EUR
Book Value
0.54 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
9 301 771 EUR
Earnings per share
-1.21 EUR
Diluted Eps TTM
-1.21 EUR
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VVY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VVY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VVY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
28.9685
Price Sales TTM
26.5973
Enterprise Value EBITDA
-24.2583
Price Book MRQ
4.1114
Financials VVY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VVY
For 52 weeks
0.41 EUR
10.05 EUR
50 Day MA
2.29 EUR
Shares Short Prior Month
–
200 Day MA
2.55 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart